Leishmania strains causing self-healing cutaneous leishmaniasis have greater susceptibility towards oxidative stress

Free Radical Research

Volumn 46, Issue 5, 2012, Pages 665-673

  Sarkar, Avijit ^a   Ghosh, Susmita ^a   Pakrashi, Sourav ^a   Roy, Debasree ^a   Sen, Sangita ^a   Chatterjee, Mitali ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anti leishmanial; Antimony resistance; Leishmaniasis; Nitric oxide; Oxidative stress; Promastigotes

Indexed keywords

ANTIMONY; FREE RADICAL; MILTEFOSINE; NITRIC OXIDE; SCAVENGER; THIOL;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HEALING; LEISHMANIA; NONHUMAN; OXIDATIVE STRESS; PROMASTIGOTE; SCAVENGING SYSTEM; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ANTIMONY; FREE RADICALS; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MACROPHAGES; NITRIC OXIDE; OXIDATIVE STRESS; PHOSPHORYLCHOLINE; SUPEROXIDE DISMUTASE;

LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR;

EID: 84859036251     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.668186     Document Type: Article

References (44)

1. New Technical Report Series on the Control of Leishmaniasis. World Health Organization (Available from: http://www.who.int/neglected-diseases/integrated- media/integrated-media-2010-leishmaniasis/en/).
2. Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dermatol 2010;7:699-705.
3. Croft SL, Yardley V, Kendrick H. Drug sensitivity of L eishmania species: some unresolved problems. Trans R Soc Trop Med Hyg 2002;96:S127-S129.
4. Croft SL. Monitoring drug resistance in leishmaniasis. Trop Med Int Health 2001;6:899-905.
5. Ashutosh, Sundar S, Goyal N. Molecular mechanisms of antimony resistance in Leishmania . J Med Microbiol 2007;56:143-153.
6. Navin TR, Arana BA, Arana FE, Berman JD, Chajón JF. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992;165:528-534.
7. Bogdan C, Röllinghoff M. How do protozoan parasites survive inside macrophages? Parasitol 1999;15:22-28.
8. Mau ël J, Ransijn A. Leishmania spp .: mechanisms of toxicity of nitrogen oxidation products. Exp Parasitol 1997;87:98-111.
9. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818-2825.
10. Souza AS, Giudice A, Pereira JM, Guimarãe s LH, de Jesus AR, de Moura TR, et al. Resistance of Leishmania ( Viannia ) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect Dis 2010;10:209.
11. Van Assche T, Deschacht M, da Luz RA, Maes L, Cos P. Leishmania- macrophage interactions: insights into the redox biology. Free Radic Biol Med 2011;51:337-351.
12. Sarkar A, Saha P, Mandal G, Mukhopadhyay D, Roy S, Singh SK, et al. Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis. Cytometry A 2011;79:35-45.
13. Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and-resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother 2010;65:496-507.
14. Saha P, Sen R, Hariharan C, Kumar D, Das P, Chatterjee M, et al. Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes. Free Radic Res 2009;43:1101-1110.
15. Sarkar A, Mandal G, Singh N, Sundar S, Chatterjee M. Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate. Exp Parasitol 2009;122:299-305.
16. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
18. Guirges SY. Natural and experimental re-infection of man with Oriental sore. Ann Trop Med Parasitol 1971;65:197-205.
19. de Oliveira JP, Fernandes F, Cruz AK, Trombela V, Monteiro E, Camargo AA, et al. Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Kinetoplastid Biol Dis 2007;6:5.
20. Solomon M, Baum S, Barzilai A, Pavlotsky F, Trau H, Schwartz E, et al. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate. J Eur Acad Dermatol Venereol 2009;23:1189-1192.
21. Murray HW. Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg 2004;71:787-794.
22. More B, Bhatt H, Kukreja V, Ainapure SS. Miltefosine: great expectations against visceral leishmaniasis. J Postgrad Med 2003;49:101-103.
23. Rakotomanga M, Blanc S, Gaudin K, Chaminade P, Loiseau PM. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes. Antimicrob Agents Chemother 2007;51:1425-1430.
24. Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, et al. Resistance of Leishmania ( Leishmania ) amazonensis and Leishmania ( Viannia ) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis. BMC Infect Dis 2007;7:7.
25. Mauël J, Corradin SB, Buchmüller Rouiller Y. Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages. Res Immunol 1991;142:577-580.
26. Mandal G, Sarkar A, Saha P, Singh N, Sundar S, Chatterjee M, et al. Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates. Indian J Biochem Biophys 2009;46:86-92.
27. Mehta A, Shaha C. Mechanism of metalloid-induced death in Leishmania spp.: role of iron, reactive oxygen species, Ca2+, and glutathione. Free Radic Biol Med 2006;40:1857-1868.
28. Wan CP, Myung E, Lau BH. An automated micro-fluorometric assay for monitoring oxidative burst activity of phagocytes. J Immunol Methods 1993;159:131-138.
29. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001;89:224-236.
30. Mandal G, Wyllie S, Singh N, Sundar S, Fairlamb AH, Chatterjee M, et al. Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology 2007;134:1679-1687.
31. Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A. Trypanothione: a novel bis(glutathionyl)-spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985;227:1485-1487.
32. Fairlamb AH, Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 1992;46:695-729.
33. Müller S, Liebau E, Walter RD, Krauth-Siegel RL. Thiolbased redox metabolism of protozoan parasites. Trends Parasitol 2003;19:320-328.
34. Reckenfelderbäumer N, Krauth-Siegel RL. Catalytic properties, thiol pK value, and redox potential of Trypanosoma brucei tryparedoxin. J Biol Chem 2002;277:17548-17555.
35. Halliwell B. Vitamin C and genomic stability. Mutat Res 2001;475:29-35.
36. Flohé L, Hecht HJ, Steinert P. Glutathione and trypanothione in parasitic hydroperoxide metabolism. Free Radic Biol Med 1999;27:966-984.
37. Wyllie S, Cunningham ML, Fairlamb AH. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani . J Biol Chem 2004;279: 39925-39932.
38. Mukhopadhyay R, Dey S, Xu N, Gage D, Lightbody J, Ouellette M, et al. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania . Proc Natl Acad Sci USA 1996;93:10383-10387.
39. Wyllie S, Mandal G, Singh N, Sundar S, Fairlamb AH, Chatterjee M, et al. Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates. Mol Biochem Parasitol 2010;173:162-164.
40. Dey R, Datta SC. Leishmanial glycosomes contain superoxide dismutase. Biochem J 1994;301:317-319.
41. Sundar S, Chatterjee M. Visceral Leishmaniasis: current therapeutic modalities. Indian J Med Res 2006;123: 345-352.
42. Mookerjee Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S, et al. Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani infected macrophages. Antimicrob Agents Chemother 2006;50:1788-1797.
43. Krauth-Siegel RL, Meiering SK, Schmidt H. The parasitespecific trypanothione metabolism of Trypanosoma and Leishmania . Biol Chem 2003;384:539-549.
44. Paramchuk WJ, Ismail SO, Bhatia A, Gedamu L. Cloning, characterization and overexpression of two iron superoxide dismutase cDNAs from Leishmania chagasi : role in pathogenesis. Mol Biochem Parasitol 1997;90:203-221.